as on October 18, 2025 at 12:37 am IST
Day's Low
Day's High
1.54%
Downside
2.56%
Upside
52 Week's Low
52 Week's High
67.93%
Downside
41.03%
Upside
Check Milestone Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$174.2M
EPS (TTM)
-0.83
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.27
Industry PE ratio
0PEG Ratio
0EBITDA
-54.9M
Revenue (TTM)
-
Profit Margin
0.00%
Return On Equity TTM
1957200.00%
Track how Milestone Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Milestone Pharmaceuticals Inc in the last 5 years
Lowest (-7.52x)
September 30, 2021
Industry (0.00x)
October 17, 2025
Today (-1.27x)
October 17, 2025
Highest (-1.30x)
March 31, 2024
Today’s Price to Earnings Ratio: -1.27x
Compare market cap, revenue, PE, and other key metrics of Milestone Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $174.2M | -72.41% | -1.27 | 0.00% | |
BUY | $61.6B | 230.86% | -505.15 | -12.96% | |
NA | $35.8B | NA | NA | -3.89% | |
BUY | $104.6B | 87.37% | 29.01 | 31.86% | |
BUY | $61.1B | -5.1% | 14.53 | 31.37% |
The Milestone Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Milestone Pharmaceuticals Inc investment value today
Current value as on today
₹1,37,567
Returns
₹37,567
(+37.57%)
Returns from Milestone Pharmaceuticals Inc Stock
₹32,653 (+32.65%)
Dollar Returns*
₹4,914 (+4.91%)
Based on 10 analysts
80.00%
Buy
20.00%
Hold
0.00%
Sell
Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Milestone Pharmaceuticals Inc. Average target price of $3.5
Get share price movements and forecasts by analysts on Milestone Pharmaceuticals Inc.
What analysts predicted
44.29%UPSIDE
Target Price
$3.5
Current Price
$1.95
Analyzed by
10 Analysts
Target
$3.50
Milestone Pharmaceuticals Inc target price $3.5, a slight upside of 44.29% compared to current price of $1.95. According to 10 analysts rating.
Search interest for Milestone Pharmaceuticals Inc Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:52% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 6 months, MIST stock has moved up by 121.6%
Revenue Rich
Revenue is up for the last 2 quarters, -868.00K → 108.0K (in $), with an average increase of 903.7% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -20.76M → -12.96M (in $), with an average increase of 60.1% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 146.6% return, outperforming this stock by 217.0%
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.1% return, outperforming this stock by 28.1%
Organisation | Milestone Pharmaceuticals Inc |
Headquarters | 1111 Dr. Frederik-Philips Boulevard, Montreal, QC, Canada, H4M 2X6 |
Industry | Pharmaceuticals: Major |
CEO | Mr. Joseph G. Oliveto M.B.A. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. Roshan Girglani | Vice President of Marketing |
Dr. Philip T. Sager FACC, FAHA, FHRS, M.D. | Chief Medical Advisor & Member of the Scientific Advisory Board |
Dr. Guy Rousseau | SVP of Regulatory Affairs and Quality Management |
Mr. Lorenz Muller | Chief Commercial Officer |
Mr. Joseph G. Oliveto M.B.A. | CEO, President & Director |
Mr. Jeffrey Nelson | Chief Operating Officer |
Dr. Philippe Douville M.B.A., Ph.D. | Founder, Strategic Advisor & Member of Scientific Advisory Board |
Mr. Jeff Moore | Vice President of Sales |
Mr. Amit Hasija | CFO & Executive VP of Corporate Development |
Dr. David B. Bharucha FACC, M.D., Ph.D. | Chief Medical Officer |
Milestone Pharmaceuticals Inc share price today is $1.95 as on . Milestone Pharmaceuticals Inc share today touched a day high of $2 and a low of $1.92.
Milestone Pharmaceuticals Inc share touched a 52 week high of $2.75 on and a 52 week low of $0.63 on . Milestone Pharmaceuticals Inc stock price today i.e. is trending at $1.95,which is 29.09% down from its 52 week high and 211.80% up from its 52 week low.
Milestone Pharmaceuticals Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Milestone Pharmaceuticals Inc (MIST) shares with as little as ₹88.054 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.54 in Milestone Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Milestone Pharmaceuticals Inc share’s latest price of $1.95 as on October 18, 2025 at 12:37 am IST, you will get 5.1282 shares of Milestone Pharmaceuticals Inc. Learn more about
fractional shares .
Milestone Pharmaceuticals Inc stock has given -72.41% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?